STAT3 and neoplasm: ASRPS can inhibit tumor progression and the mechanism is that the ASRPS peptide binds STAT3 directly through the coiled coil domain (CCD), and then down-regulates the phosphorylation of STAT3, resulting in a decrease in the expression of VEGF [26].